CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,836 | -88.5% | 12,400 | -85.8% | 0.00% | -90.0% |
| Q2 2023 | $4,896,867 | -48.4% | 87,226 | -58.5% | 0.02% | -56.5% |
| Q1 2023 | $9,495,631 | +30.7% | 209,941 | +17.4% | 0.05% | -4.2% |
| Q4 2022 | $7,266,350 | -99.9% | 178,754 | +98.4% | 0.05% | +4.3% |
| Q3 2022 | $5,888,035,000 | -27.7% | 90,100 | -32.7% | 0.05% | -37.8% |
| Q2 2022 | $8,139,655,000 | -61.9% | 133,942 | -60.7% | 0.07% | -57.5% |
| Q1 2022 | $21,371,427,000 | +152.8% | 340,472 | +205.2% | 0.17% | +185.2% |
| Q4 2021 | $8,452,576,000 | -45.8% | 111,541 | -20.0% | 0.06% | -47.0% |
| Q3 2021 | $15,599,348,000 | +157.6% | 139,367 | +272.6% | 0.12% | +139.6% |
| Q2 2021 | $6,055,657,000 | -62.0% | 37,406 | -71.4% | 0.05% | -72.6% |
| Q1 2021 | $15,926,160,000 | +1653.7% | 130,703 | +1103.7% | 0.18% | +1490.9% |
| Q3 2020 | $908,163,000 | -25.1% | 10,858 | -34.2% | 0.01% | -42.1% |
| Q2 2020 | $1,212,585,000 | +116048.0% | 16,500 | -33.0% | 0.02% | +11.8% |
| Q1 2020 | $1,044,000 | +394.8% | 24,635 | +609.9% | 0.02% | +750.0% |
| Q4 2019 | $211,000 | -56.9% | 3,470 | -79.7% | 0.00% | -50.0% |
| Q4 2018 | $489,000 | -88.3% | 17,100 | -81.8% | 0.00% | -82.6% |
| Q3 2018 | $4,171,000 | – | 94,040 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |